Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 154-42-7 Chemical Structure| 154-42-7

Structure of 6-Thioguanine
CAS No.: 154-42-7

Chemical Structure| 154-42-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

6-Thioguanine belongs to the thiopurine family of drugs that also include mercaptopurine and azathioprine, which are examples of antimetabolites, and is a purine analogue of the nucleobase guanine. It was found to inhibit SARS-CoV PLpro. 6-Thioguanine disrupts cytosine methylation by DNA methyltransferases in vitro and acts as a DNA demethylating agent in vivo.

Synonyms: Thioguanine; 2-Amino-6-purinethiol; 6Mercapto2aminopurine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 6-Thioguanine

CAS No. :154-42-7
Formula : C5H5N5S
M.W : 167.19
SMILES Code : S=C1N=C(N)NC2=C1NC=N2
Synonyms :
Thioguanine; 2-Amino-6-purinethiol; 6Mercapto2aminopurine
MDL No. :MFCD02730136
InChI Key :WYWHKKSPHMUBEB-UHFFFAOYSA-N
Pubchem ID :2723601

Safety of 6-Thioguanine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P310+P330-P405
Class:6.1
UN#:2811
Packing Group:

Related Pathways of 6-Thioguanine

epigenetics
DNA

Isoform Comparison

Biological Activity

Target
  • DNA Methyltransferase

In Vitro:

Cell Line
Concentration Treated Time Description References
Jurkat T cells 3 μM 24 hours Measure the replacement rate of SG in DNA, results showed approximately 10% of guanine was replaced with SG PMC2922690
HL-60 cells 3 μM 24 hours Measure the replacement rate of SG in DNA, results showed approximately 7.4% of guanine was replaced with SG PMC2922690
CCRF-CEM cells 3 μM 24 hours Measure the replacement rate of SG in DNA, results showed approximately 7% of guanine was replaced with SG PMC2922690
K-562 cells 3 μM 24 hours Measure the replacement rate of SG in DNA, results showed approximately 3% of guanine was replaced with SG PMC2922690
HCT-116 cells 3 μM 24 hours Measure the replacement rate of SG in DNA, results showed approximately 0.2% of guanine was replaced with SG PMC2922690
HEK293T cells 3.6 μM (EC50) 48 hours Evaluate the antiproliferative activity of 6-TG, results show HEK293T cells are highly sensitive to 6-TG PMC9706553
K-562 cells 0.7 μM (EC50) 48 hours Evaluate the antiproliferative activity of 6-TG on K-562 cells, results show K-562 cells are sensitive to 6-TG PMC9706553
THP-1 cells 0.3 μM (EC50) 48 hours Evaluate the antiproliferative activity of 6-TG on THP-1 cells, results show THP-1 cells are sensitive to 6-TG PMC9706553
HCT116 cells 150 nM 72 hours To investigate the effect of NUDT15 knockdown on 6-TG-induced checkpoint activation, results showed that NUDT15 knockdown significantly enhanced 6-TG-induced Chk1 and Chk2 phosphorylation PMC6847052

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03334266 Obesity Infan... More >>t Obesity Mother-Child Relations Dietary Habits Breast Feeding Physical Activity Childhood Obesity Feeding Behavior Less << Not Applicable Recruiting December 31, 2021 United States, Arizona ... More >> Johns Hopkins Center for American Indian Health Recruiting Fort Defiance, Arizona, United States, 86504 Contact: Allison Barlow, PhD    410-955-6931    abarlow@jhu.edu    Contact: Nicole Neault, MPH    5057973309    nneault@jhu.edu    Johns Hopkins Center for American Indian Health Recruiting Whiteriver, Arizona, United States, 85941 Contact: Allison Barlow, PhD    410-955-6931    abarlow@jhu.edu    Contact: Nicole Neault, MPH    5057973309    nneault@jhu.edu    United States, New Mexico Johns Hopkins Center for American Indian Health Recruiting Shiprock, New Mexico, United States, 87420 Contact: Allison Barlow, PhD    410-955-6931    abarlow@jhu.edu    Contact: Nicole Neault, MPH    5057973309    nneault@jhu.edu Less <<
NCT02281799 Pancreatitis ... More >>Inflammatory Bowel Diseases Less << Phase 4 Recruiting January 2019 Israel ... More >> Shaare Zedek Recruiting Jerusalem, Israel, 91031 Less <<
NCT02046694 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Early Phase 1 Recruiting September 2021 United States, Maryland ... More >> Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21287 Principal Investigator: Colleen Annesley, MD          Sub-Investigator: Patrick A Brown, MD          United States, Texas Texas Children's Cancer and Hematology Centers Recruiting Houston, Texas, United States, 77030 Contact: Julie Brackett, MD    832-822-4242       Sub-Investigator: Edward Sisson, MD          Principal Investigator: Julie Brackett, MD          United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Colleen Annesley, MD          Principal Investigator: Colleen Annesley, MD Less <<
NCT00022126 Leukemia Phase 2 Completed - -
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT00002514 Leukemia Phase 3 Completed - -
NCT00002517 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Hospitalier Regional de Lille Lille, France, 59037 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34295 CHR Hotel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hopital Robert Debre Paris, France, 75019 Institut Curie - Section Medicale Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants (Purpan Enfants) Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Less <<
NCT00002812 Leukemia Phase 3 Completed - -
NCT00003437 Leukemia Phase 3 Unknown - United Kingdom ... More >> Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Less <<
NCT00005603 Leukemia Phase 3 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States, 94304 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0128 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Illinois Saint Jude Midwest Affiliate Peoria, Illinois, United States, 61637 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216-4505 United States, New York Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio Children's Hospital Medical Center - Cincinnati Cincinnati, Ohio, United States, 45229-3039 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97201-3098 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555-0361 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00003728 Leukemia Lymp... More >>homa Less << Phase 3 Unknown - Belgium ... More >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Ghent University Ghent, Belgium, B-9000 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34059 CHR Hotel Dieu Nantes, France, 44035 Hopital de l'Archet CHU de Nice Nice, France, F-06202 CHU - Hopital Robert Debre Paris, France, 75019 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Instituto Portugues de Oncologia Centro do Porto, SA Porto, Portugal, 4200 Less <<
NCT00002701 Leukemia Phase 3 Unknown - -
NCT00005823 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2RR University College Hospital London, England, United Kingdom, WC1E 6AU University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT00002658 Leukemia Neut... More >>ropenia Less << Phase 3 Unknown - United Kingdom ... More >> University of Wales College of Medicine Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT00002531 Leukemia Phase 2 Unknown - Germany ... More >> Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Less <<
NCT00002665 Leukemia Neut... More >>ropenia Thrombocytopenia Less << Phase 2 Completed - -
NCT00198991 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)69 6301 5194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)69 6301 6365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT00199004 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital of Frankfurt, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00003423 Lymphoma Phase 3 Unknown - United Kingdom ... More >> Hospital for Sick Children NHS Trust London, England, United Kingdom, WC1N 3JH Less <<
NCT00343369 Leukemia Not Applicable Unknown - Germany ... More >> Evangelisches Krankenhauus Bielfeld Recruiting Biefeld, Germany, 33617 Contact: N. Jorch, MD    49-52-177-278-050       Klinikum Bremen-Mitte Recruiting Bremen, Germany, D-28205 Contact: Arnulf Pekrun, MD, PhD    49-421-497-3656    arnulf.pekrun@klinikum-bremen-mitte.de    Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person    49-211-311-7990       Universitats - Kinderklinik Recruiting Greiswald, Germany, 17487 Contact: James F. Beck, MD    49-383-486-6325    beck@uni-greifswald.de    University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub    49-404-2803-2580       Kreskrankenhaus Kinderabteilung Recruiting Heide, Germany, 25746 Contact: Streitberger    49-481-785-911       Clinic for Bone Marrow Transplantation and Hematology and Oncology Recruiting Idar-Oberstein, Germany, D-55743 Contact: Wenzel Nuernberger, MD, PhD    49-6781-66-1582    wnuernberger@bmt-center-io.com    Klinikum Krefeld GmbH Recruiting Krefeld, Germany, D-47805 Contact: P. Thomas    49-2151-322-375       Universitaets - Kinderklinik Recruiting Leipzig, Germany, D-04317 Contact: Dieter Koerholz, MD    49-341-9726-246    koerd@medizin.uni-leipzig.de    Johannes Gutenberg University Recruiting Mainz, Germany, D-55101 Contact: P. Gutjahr, MD    49-6131-17-2112       Krankenhaus Neuwerk Klinik fuer Kinder und Jugendmedizin Recruiting Moenchengladbach, Germany, D-41066 Contact: Wolfgang Mueller, MD    49-2161-668-2481       Dr. von Haunersches Kinderspital der Universitaet Muenchen Recruiting Munich, Germany, D-80337 Contact: Arndt Borkhardt    49-89-5160-4498       Staedtisches Krankenhaus Muenchen - Harlaching Recruiting Munich, Germany, D-81545 Contact: Papucek    49-89-6210-2710       Klinik St. Hedwig-Kinderklinik Recruiting Regensburg, Germany, 93049 Contact: Ove Peters    49-941-369-5404       Dr. Horst-Schmidt-Kliniken Recruiting Wiesbaden, Germany, D-65199 Contact: Gerhard Beron, MD    49-611-43-2564       Helios Kliniken Wuppertal University Hospital Recruiting Wuppertal, Germany, D-42283 Contact: B. Dohrn, MD    49-202-896-3823    bdohrn@wuppertal.helios-klinikum.de Less <<
NCT00275106 Lymphoma Phase 3 Terminated(Withdrawn due to an... More >> excess of toxic deaths) Less << - Germany ... More >> Kinderklinik Giessen, Germany, D-35385 Ireland Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00199056 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00199017 Lymphoma, Lymphoblastic Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00558519 Leukemia Phase 2 Active, not recruiting - -
NCT00430118 Leukemia Phase 3 Completed - -
NCT00764907 Leukemia Phase 3 Unknown - Czech Republic ... More >> University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD    420-2-2443-6401    jan.stary@lfmotol.cuni.cz Less <<
NCT00550992 Leukemia Not Applicable Unknown - United States, Massachusetts ... More >> Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis B. Silverman, MD    617-632-5285       United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Clinical Trials Office - St. Jude Children's Research Hospital    901-595-4644       United States, Texas M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U    713-792-3245       United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Blythe Thomson, MD    206-987-2106       Austria St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Georg Mann, MD    43-1-4017-1250       Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Alice Ferster, MD    32-2-477-2678    aferster@ulb.ac.be    Czech Republic University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD    420-2-2443-6401    jan.stary@lfmotol.cuni.cz    France CHR Hotel Dieu Recruiting Nantes, France, 44093 Contact: Francoise Mechinaud, MD    33-1-4249-9046       Germany University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub    49-404-2803-2580       Medizinische Hochschule Hannover Recruiting Hannover, Germany, D-30625 Contact: Martin Schrappe, MD, PhD    49-511-532-6713       Italy Nuovo Ospedale San Gerardo at University of Milano-Bicocca Recruiting Monza, Italy, 20052 Contact: Andrea Biondi, MD    39-039-233-3661    biondi@galactica.it    Netherlands Erasmus MC - Sophia Children's Hospital Recruiting Rotterdam, Netherlands, 3015 GJ Contact: Rob Pieters, MD, MSC, PhD    31-10-463-6691    rob.pieters@erasmusmc.nl    United Kingdom Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Phil Ancliff, MD    44-20-7829-8831 Less <<
NCT02723994 Leukemia Phase 2 Recruiting May 2024 -
NCT01117441 Leukemia Phase 3 Active, not recruiting December 2021 -
NCT03150693 B Acute Lymphoblastic Leukemia Phase 3 Recruiting August 2024 -
NCT00098111 Crohn's Disease Phase 3 Terminated(Lack of recruitment... More >>) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03571321 Acute Lymphoblastic Leukemia ... More >> ALL, Childhood ALL Less << Phase 1 Not yet recruiting September 5, 2024 United States, Illinois ... More >> University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Howie Weiner    773-702-2084    hweiner@medicine.bsd.uchicago.edu    Contact: Peggy Green, RN    (773) 702-0267    mgreen@medicine.bsd.uchicago.edu    Principal Investigator: Emily Currant, MD Less <<
NCT01770444 Chest Pain Not Applicable Completed - Korea, Republic of ... More >> Seoul national university Bundang hospital Seongnam-si, Korea, Republic of, 463-707 Asan Medical Center Seoul, Korea, Republic of, 138-736 Seoul national university Boramae medical center Seoul, Korea, Republic of, 156-707 Less <<
NCT01156883 Leukemia Not Applicable Completed - Italy ... More >> Complesso Ospedaliero S. Giovanni Addolorata Roma, (rm), Italy, 00184 Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy USL 8 - Ospedale S.Donato Arezzo, Italy Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Az.Ospedaliera S.G.Moscati Avellino, Italy UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Divisione di Ematologia Ospedale A. Perrino Brindisi, Italy Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Catanzaro, Italy Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna Ferrara, Italy Divisione Ematologia 1 - Azienda Ospedaliera Universitaria "San Martino" Genova, Italy ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Ospedale Niguarda " Ca Granda" Milano, Italy Centro Oncologico Modenese - Dipartimento di Oncoematologia Modena, Italy Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy UOSC di Ematologia Oncologica - Istituto Nazionale Tumori "Fondazione Senatore Giovanni Pascale" Napoli, Italy zienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Inferiore U.O. Medicina Interna Ematologia ed Oncologia P.O. Umberto I Nocera Inferiore, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Divisione di Ematologia con trapianto di midollo - A.U. Policlinico "Paolo Giaccone" Palermo, Italy Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy Cattedra di Ematologia CTMO Università degli Studi di Parma Parma, Italy S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo Pavia, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Università di Pisa - Azienda Ospedaliera Pisana - Dipartimento di Oncologia, dei Trapianti e delle nuove Tecnologie in Medicina - Divisione di Ematologia Pisa, Italy Dipartimento Oncologico - Ospedale S.Maria delle Croci Ravenna, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Reggio Emilia, Italy Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia Roma, Italy Divisione di Ematologia - Ospedale S. Camillo Divisione di Ematologia - Ospedale S. Camillo Roma, Italy Divisione Ematologia - Università Campus Bio-Medico Roma, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza S. G. Rotondo, Italy Serv. di Ematologia Ist. di Ematologia ed Endocrinologia Sassari, Italy Struttura Complessa Ematologia - Azienda Sanitaria Locale BAT1- Presidio Ospedaliero Bisceglie-Trani Trani, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Verona, Italy Less <<
NCT02101853 B Acute Lymphoblastic Leukemia Phase 3 Recruiting - -
NCT02112916 Adult T Acute Lymphoblastic Le... More >>ukemia Ann Arbor Stage II Adult Lymphoblastic Lymphoma Ann Arbor Stage II Childhood Lymphoblastic Lymphoma Ann Arbor Stage III Adult Lymphoblastic Lymphoma Ann Arbor Stage III Childhood Lymphoblastic Lymphoma Ann Arbor Stage IV Adult Lymphoblastic Lymphoma Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma Childhood T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Suspended(Other - Temporary cl... More >>osure) Less << - -
NCT01190930 Acute Lymphoblastic Leukemia ... More >> Adult B Lymphoblastic Lymphoma Ann Arbor Stage I B Lymphoblastic Lymphoma Ann Arbor Stage II B Lymphoblastic Lymphoma Childhood B Acute Lymphoblastic Leukemia Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Childhood B Lymphoblastic Lymphoma Down Syndrome Hypodiploid B Acute Lymphoblastic Leukemia Intrachromosomal Amplification of Chromosome 21 Philadelphia Chromosome Positive Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Active, not recruiting - -
NCT02894645 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 4 Unknown - Malaysia ... More >> University of Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS    +603 7949 6785    hany@ummc.edu.my    Subang Jaya Medical Centre Recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS       flslhp@gmail.com    Contact: Lee Lee Chan, MBBS       drchanleelee@gmail.com    Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS    (+65) 6772 4406    allen_yeoh@nuhs.edu.sg    KK Women's and Children's Hospital Recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS    (+65) 63941039    tan.ah.moy01@singhealth.com.sg Less <<
NCT03643276 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting July 14, 2028 -
NCT02297126 Adverse Drug Reaction Not Applicable Completed - United States, Indiana ... More >> Eskenazi Health System Indianapolis, Indiana, United States, 46250 Less <<
NCT02883049 B Acute Lymphoblastic Leukemia... More >> Central Nervous System Leukemia Ph-Like Acute Lymphoblastic Leukemia Testicular Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting - -
NCT00199069 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany Less <<
NCT03007147 B Acute Lymphoblastic Leukemia... More >> BCR-ABL1 Fusion Protein Expression Minimal Residual Disease Philadelphia Chromosome Positive T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting June 30, 2026 -
NCT02665065 Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << Phase 3 Recruiting June 2020 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less <<
NCT00266136 Acute Myeloid Leukemia Phase 3 Completed - Germany ... More >> University of Muenster, Medical Center, Department of Medicine, Hematology and Oncology Muenster, Germany, 48129 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01456871 - Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT00005945 Leukemia Phase 3 Completed - -
NCT00439296 Recurrent Pediatric ALL ... More >> Relapsed Pediatric ALL Acute Lymphoblastic Leukemia Refractory Pediatric ALL Less << Phase 1 Terminated(The study was stopp... More >>ed due to poor accrual and lack of funding.) Less << - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 United States, New York New York University Medical Center New York, New York, United States, 10016 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00002590 Lymphoma Phase 2 Completed - -
NCT00003671 Leukemia Phase 2 Completed - -
NCT00925873 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> GOELAMS Tours, France, 37000 Less <<
NCT00613457 Leukemia Phase 3 Completed - -
NCT00002798 Childhood Acute Erythroleukemi... More >>a (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00016302 T-cell Childhood Acute Lymphob... More >>lastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00075725 Leukemia Phase 3 Completed - -
NCT00408005 T Acute Lymphoblastic Leukemia... More >> T Lymphoblastic Lymphoma Less << Phase 3 Completed - -
NCT00004056 Leukemia Phase 1 Completed - -
NCT00004228 - Unknown - -
NCT00005585 Leukemia Phase 3 Completed - -
NCT02179450 - Completed - Austria ... More >> Department of Neurology, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00186966 Acute Myeloid Leukemia Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00004228 Lymphoma Phase 3 Unknown - -
NCT00671034 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - -
NCT01228331 Leukemia Phase 2 Phase 3 Recruiting September 2021 Germany ... More >> Krankenanstalten Gilead gCmbH Neurochirurgische Klinik Recruiting Bielefeld, Germany, 33617 Contact: Contact Person    49-521-144-2728       Klinikum Bremen-Mitte Recruiting Bremen, Germany, D-28205 Contact: Contact Person    49-421-497-5413       Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person    49-211-81-17662       Klinik und Poliklinik Fuer Kinder-und Jugendmedizin - Universitaetsklinikum Greifswald Recruiting Greifswald, Germany, 17487 Contact: Contact Person    49-3834-86-6321       University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Contact Person    49-407-4105-2580    horstmann@uke.uni-hamburg.de    Clinic for Bone Marrow Transplantation and Hematology and Oncology Recruiting Idar-Oberstein, Germany, D-55743 Contact: Contact Person    49-6781-66-1582       Klinikum Krefeld GmbH Recruiting Krefeld, Germany, D-47805 Contact: Contact Person    49-2151-322-375       Universitaets - Kinderklinik Recruiting Leipzig, Germany, D-04317 Contact: Contact Person    49-341-9726-113       Johannes Gutenberg University Recruiting Mainz, Germany, D-55101 Contact: Contact Person    49-6131-17-2642       Dr. von Haunersches Kinderspital der Universitaet Muenchen Recruiting Munich, Germany, D-80337 Contact: Contact Person    49-89-5160-2843       Staedtisches Krankenhaus Muenchen - Harlaching Recruiting Munich, Germany, D-81545 Contact: Contact Person    49-89-6210-2720       Klinik St. Hedwig-Kinderklinik Recruiting Regensburg, Germany, 93049 Contact: Contact Person    49-941-2080-493       Dr. Horst-Schmidt-Kliniken Recruiting Wiesbaden, Germany, D-65199 Contact: Contact Person    49-611-43-2564       Helios Kliniken Wuppertal University Hospital Recruiting Wuppertal, Germany, D-42283 Contact: Contact Person    49-202-896-2444 Less <<
NCT00075725 - Completed - -
NCT00103285 B-cell Childhood Acute Lymphob... More >>lastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT00103285 - Completed - -
NCT01451515 Lymphoblastic Lymphoma Phase 2 Active, not recruiting June 30, 2021 United States, California ... More >> Rady Children's Hospital San Diego San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00005596 Leukemia Phase 3 Completed - -
NCT00671034 - Completed - -
NCT00109837 - Completed - -
NCT00109837 Leukemia Phase 2 Completed - -
NCT02521493 Blasts 5 Percent or More of Bo... More >>ne Marrow Nucleated Cells Childhood Acute Myeloid Leukemia Childhood Myelodysplastic Syndrome Cytopenia Down Syndrome Myeloid Leukemia Associated With Down Syndrome Myeloproliferative Neoplasm Trisomy 21 Trisomy 21 Mosaicism Less << Phase 3 Recruiting - -
NCT00113503 Crohn's Disease Phase 2 Terminated(Insufficient enroll... More >>ment) Less << - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Georgia Atlanta Gastroenterology Associates, LLC Atlanta, Georgia, United States, 30342 United States, Illinois University of Chicago Pediatric Gastroenterology Chicago, Illinois, United States, 60637 University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Minnesota Duluth Clinic Duluth, Minnesota, United States, 55805 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Long Island Clinical Research Assoc. Great Neck, New York, United States, 11021 Mt. Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States, 27514 United States, Ohio Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45229 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G2X8 Canada, Ontario London Health Sciences Centre London, Ontario, Canada, N6A5A5 Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01432145 Breast Cancer ... More >> Ovarian Cancer Less << Phase 2 Completed - United Kingdom ... More >> Churchill Hospital Oxford, United Kingdom, OX3 7LJ Less <<
NCT00003593 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - -
NCT00866307 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, Arizona ... More >> Phoenix Childrens Hospital Phoenix, Arizona, United States, 85016 United States, California Miller Children's Hospital Long Beach, California, United States, 90806 Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Rady Children's Hospital - San Diego San Diego, California, United States, 92123 University of California San Francisco Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Florida Nemours Children's Clinic-Jacksonville South Jacksonville, Florida, United States, 32207 United States, Georgia Children's Healthcare of Atlanta - Egleston Atlanta, Georgia, United States, 30322 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 Kosair Children's Hospital Louisville, Kentucky, United States, 40202 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, New York The Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park, New York, United States, 11040 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Legacy Emanuel Children's Hospital Portland, Oregon, United States, 97227 Legacy Emanuel Hospital and Health Center Portland, Oregon, United States, 97227 United States, Pennsylvania Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Methodist Children's Hospital of South Texas San Antonio, Texas, United States, 78229 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6008 Canada, Ontario Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT00176462 - Completed - -
NCT02419469 Leukemia Prec... More >>ursor-B Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Lymphoma Less << Phase 2 Terminated(Slow Accrual) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02419469 - Terminated(Slow Accrual) - -
NCT00866307 - Completed - -
NCT00548431 Leukemia, Lymphocytic, Acute Phase 2 Completed - Denmark ... More >> Department of Pediatrics, Rigshospitalet Copenhagen, Denmark Department of Pediatrics, University Hospital Odense, Denmark Sweden Department of Pediatrics, Drottning Sylvias Pediatric Hospital Gothenburg, Sweden Less <<
NCT00002816 Leukemia Phase 3 Completed - -
NCT02828358 Acute Leukemia of Ambiguous Li... More >>neage Childhood B Acute Lymphoblastic Leukemia KMT2A Gene Rearrangement Mixed Phenotype Acute Leukemia Less << Phase 2 Suspended(Met accural pending ... More >>evaluation of enrolled pats.) Less << September 30, 2019 -
NCT00548431 - Completed - -
NCT02660762 Leukaemia,Lymphoblastic Phase 2 Recruiting January 2019 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: yue lu, MD.    0086-02087342438    dr_luyue@sina.com Less <<
NCT00176462 Acute Lymphocytic Leukemia Phase 2 Completed - United States, New Jersey ... More >> Jersey Shore University Medical Center Neptune, New Jersey, United States, 07754 Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT00866749 Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00002744 Leukemia Phase 3 Completed - -
NCT00369317 Childhood Acute Basophilic Leu... More >>kemia Childhood Acute Eosinophilic Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - -
NCT00184041 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90032 Less <<
NCT00002944 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 3 Completed - -
NCT00849368 Inflammatory Bowel Disease Phase 1 Completed - Switzerland ... More >> Division of Clinical Pharmacology and Toxicology, University Hospital Zurich Zurich, Switzerland, CH-8091 Less <<
NCT02598908 - Recruiting February 24, 2022 United Kingdom ... More >> Department of Biochemistry, City Hospital Recruiting Birmingham, West Midlands, United Kingdom Contact: Jonathan Berg, FRCPath    01215075345    jonathanberg@nhs.net    Contact: Jenna Waldron, FRCPath    01215075025    jenna.waldron@nhs.net Less <<
NCT00549848 Acute Lymphoblastic Leukemia Phase 3 Active, not recruiting November 30, 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03022747 Lymphoblastic Leukemia, Acute,... More >> Childhood Less << Phase 2 Recruiting April 2019 Finland ... More >> Dept of Pediatrics and Adolescents, Oulu University Hospital, Box 23, 90029 OYS, Finland Not yet recruiting Oulu, Finland, 90029 OYS Contact: Riita Niinimäki, MD, PhD    +358 8 3155832    riita.niinimaki@ppshp.fi    Sweden Childrens' Cancer Centre, Queen Silvias Childrens and Adolescents Hospital Recruiting Gothenburg, Sweden, 416 85 Contact: Lene Karlsson, MD    +46 313435610    lene.karlsson@vgregion.se    Linköping University Hospital, Dept of Pediatrics Not yet recruiting Linköping, Sweden, 58185 Contact: Hartmut Vogt, MD, PhD    +46 101031343    hartmut.vogt@regionostergotland.se Less <<
NCT00504660 - Completed - -
NCT00587873 Hodgkin's Disease Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00369317 - Completed - -
NCT00588536 Langerhans Cell Histiocytosis Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00588536 - Completed - -
NCT02912676 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 1 Phase 2 Recruiting December 2018 Denmark ... More >> Department of Pediatrics, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Kjeld Schmiegelow, MD    +45 3545 1357    kjeld.schmiegelow@rh.regionh.dk    Contact: Rikke H Larsen, MD    +45 35457093    rikke.hebo.larsen.01@regionh.dk    Sub-Investigator: Rikke H Larsen, MD          Rigshospitalet, Department of Hematology Recruiting Copenhagen, Denmark, 2100 Contact: Cecilie U Rank, M.D.    +45 35454534    cecilie.utke.rank@regionh.dk    Contact: Ove J Nielsen, M.D.    +45 35451144    ove.jul.nielsen@regionh.dk Less <<
NCT02141100 Non-Hodgkin Lymphoma Phase 1 Phase 2 Withdrawn October 2016 Denmark ... More >> Dept. of Pediatric Oncology, JMC, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00504660 Anaplastic Glioma of Brain ... More >> Glioblastoma Multiforme Brain Cancer Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.98mL

1.20mL

0.60mL

29.91mL

5.98mL

2.99mL

59.81mL

11.96mL

5.98mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories